The Recall Desk
HighFDA (Devices)·Z-0959-2026·Announced 2025-12-24

Leukemia test kits recalled in a second lot family over inaccurate results

Cepheid is recalling 6,325 Xpert BCR-ABL Ultra kits, catalog GXBCRABL-US-10, because specimens with an elevated white blood cell count above 30,000 cells may cause inaccurate results.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: the firm states specimens with elevated white cell counts may produce inaccurate results, and no injuries are reported.

Plain-English summary

The Cepheid Xpert BCR-ABL Ultra, model GXBCRABL-US-10, is being recalled.

In vitro diagnostic test kits used with specimens that have an elevated white blood cell count, above 30,000 cells, may cause inaccurate results.

The record lists 6,325 units carrying UDI 07332940007102, across lot numbers including 1001456698, 1001463946, 1001472599, 1001477457, 1001480637 and 1001483326. Distribution covered a wide range of US states and countries outside the United States. The FDA has classified the action as Class II.

An inaccurate result on a diagnostic test can affect the clinical decisions made from it. The enforcement record reports no injuries. Laboratories should follow Cepheid's instructions.

The recalled product

Product
Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GXBCRABL-US-10
Manufacturer
Cepheid
Hazard
  • inaccurate-results
  • diagnostic-test
  • specimen-interference

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (7)

  • UDI: 07332940007102/ Lot Numbers: 1001456698
  • 1001463946
  • 1001472599
  • 1001477457
  • 1001480637
  • 1001483326
  • 1001500425

Distribution

Distributed in 29 states:

  • AL
  • AR
  • AZ
  • CA
  • CO
  • FL
  • GA
  • IA
  • IL
  • KS
  • KY
  • LA
  • MD
  • ME
  • MI
  • MN
  • MO
  • NC
  • NE
  • NH
  • NJ
  • NY
  • OH
  • PA
  • RI
  • TX
  • VA
  • WA
  • WI